What the New VA and HHS Partnership Means for Psychedelic Therapy for Veterans
On July 13, 2026, the VA and HHS signed a five-year partnership to research psychedelic-assisted therapy for veterans, including psilocybin, MDMA, ketamine, and ibogaine. It could touch more than one million veterans living with serious mental illness. Here is what it covers, what it does not mean yet, and how to explore options.
By Rev. Jemie Sae Koo, M.A.











